首页> 外文期刊>Nephron Extra >Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
【24h】

Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration

机译:持续性静脉血液滤过对非感染性重症急性肾脏损伤患者的疗效决定因素

获取原文
           

摘要

Background/Aims: In view of ongoing controversy, we wished to study whether patient characteristics and/or continuous venovenous hemofiltration (CVVH) characteristics contribute to the outcome of non-septic critically ill patients with acute kidney injury (AKI). Methods: We retrospectively studied 102 consecutive patients in the intensive care unit (ICU) with non-septic AKI needing CVVH. Patient and CVVH characteristics were evaluated. Primary outcome was mortality up to day 28 after CVVH initiation. Results: Forty-four patients (43%) died during the 28-day period after the start of CVVH. In univariate analyses, non-survivors had more often a cardiovascular reason for ICU admission, greater disease acuity/severity and organ failure, lower initial creatinine levels, less use of heparin and more use of bicarbonate-based substitution fluid. The latter two can be attributed to high lactate levels and bleeding tendency in non-survivors necessitating withholding lactate-buffered fluid and heparin, respectively, according to our clinical protocol. In multivariate analyses, mortality was predicted by disease severity, use of bicarbonate-based fluids and lack of heparin, while initial creatinine and CVVH dose did not contribute. Conclusion: The outcome of non-septic AKI in need of CVVH is more likely to be determined by underlying or concurrent, acute and severe disease rather than by CVVH characteristics, including timing and dose.
机译:背景/目的:鉴于持续的争议,我们希望研究患者特征和/或持续静脉静脉血液滤过(CVVH)特征是否有助于非败血症性急性肾损伤(AKI)重症患者的预后。方法:我们回顾性研究了重症监护病房(ICU)中102例需要CVVH的非感染性AKI患者。评估患者和CVVH特征。主要结果是CVVH启动后直至第28天的死亡率。结果:在开始CVVH后的28天内,有44名患者(43%)死亡。在单因素分析中,非幸存者更多是因心血管原因导致ICU入院,疾病敏锐度/严重性和器官衰竭,初始肌酐水平降低,肝素使用量减少以及碳酸氢盐替代液使用量增加。根据我们的临床方案,后两者可归因于高乳酸水平和非幸存者的出血倾向,分别需要保留乳酸缓冲液和肝素。在多变量分析中,死亡率是通过疾病的严重程度,使用碳酸氢盐类液体和缺乏肝素来预测的,而最初的肌酐和CVVH剂量则没有影响。结论:需要CVVH的非败血症性AKI的结果更可能由潜在或并发的急性和严重疾病决定,而不是由CVVH的特征(包括时间和剂量)决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号